We’re the Australian Biotech Platform Translating Cellular Science into Regulated Longevity Solutions for Global Markets
Longevity Life Sciences (LLS) is pioneering the future of evidence-based longevity. As an integrated biotech company, LLS unites research, innovation, and commercialisation to bridge the gap between scientific discovery and market application.
A leader in NAD+ science, Longevity Life Sciences operates at the intersection of nutraceuticals, pharmaceuticals, and skincare science, translating cellular research into regulated, real-world applications.
LLS operates as a vertically integrated longevity biotech company, combining a dedicated research institute, advanced ingredient innovation, and commercial B2B and DTC pathways.
This ecosystem bridges the full continuum from scientific discovery to clinical validation and real-world application, ensuring every new innovation is evidence-based, regulatory-ready, and commercially scalable.
Our Scientific & Medical Advisory Board
Our Research Partners
Through the LLS Research Institute and its partnership with the University of Sydney and NICM, the company delivers world-first clinical evidence that meets regulator-grade standards and reinforces its leadership in credible, science-backed innovation.
Leading the Global Shift Toward Evidence-Based Longevity Solutions to Increase Healthspan.
Pioneering the Future of Longevity Science
LLS is helping to shape a new era of longevity science built on evidence, not opinion. As a pioneering Australian biotech company, it is leading the global shift toward clinically proven, preventative health solutions.